Arthur Tzianabos - Mar 25, 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Stock symbol
QTTB
Transactions as of
Mar 25, 2024
Transactions value $
-$6,413
Form type
4
Date filed
8/14/2024, 04:05 PM
Previous filing
Feb 15, 2024
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTTB Common Stock Options Exercise +1.1K +15.31% 8.25K Mar 25, 2024 Direct F1, F2
transaction QTTB Common Stock Sale -$6.41K -265 -3.21% $24.20 7.98K Mar 25, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTTB Restricted Stock Units Options Exercise $0 -1.1K -100% $0.00* 0 Mar 25, 2024 Common Stock 1.1K Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.
F2 The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.
F3 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
F4 The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.